文献速递脊柱关节炎

血清可溶性标志物鉴别银屑病关节炎与骨关节炎

Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis.
PubMed 文献 · Ann Rheum Dis · 2019-03-25

研究比较了201例骨关节炎、77例银屑病关节炎和76例对照的血清标志物,发现COMP、resistin、MCP-1和NGF独立关联于银屑病关节炎与骨关节炎的鉴别,多变量模型AUROC为0.99,并在独立样本中验证得到相似结果。

要点

  • 四标志物组合模型(COMP、resistin、MCP-1、NGF)可区分银屑病关节炎与骨关节炎,AUROC达0.99。
  • 软骨代谢、代谢综合征和炎症相关标志物在三组间均有显著差异(p<0.001)。
  • 验证样本中模型表现相似,但需前瞻性研究进一步验证。

核心结论

  • 由COMP、resistin、MCP-1和NGF组成的四标志物组合可能区分银屑病关节炎与骨关节炎。
  • 该模型区分能力优于仅用年龄和性别的模型(AUROC 0.99 vs 0.87,p<0.001)。

研究设计与样本

  • 比较201例骨关节炎、77例银屑病关节炎和76例对照的血清标志物水平。
  • 采用Kruskal-Wallis检验进行组间比较,Wilcoxon秩和检验进行两两比较,多变量逻辑回归筛选鉴别标志物并构建ROC曲线。
  • 在独立验证集(73例银屑病关节炎和75例骨关节炎)中验证最终模型。

主要发现

  • COMP、透明质酸、resistin、HGF、胰岛素、瘦素、CRP、IL-6、IL-8、TNFα、MCP-1和NGF在三组间水平差异显著(p<0.001)。
  • 多变量分析中,COMP(OR 1.24,95%CI 1.06至1.46)、resistin(OR 1.26,95%CI 1.07至1.48)、MCP-1(OR 1.10,95%CI 0.07至1.48)和NGF(OR<0.001,95%CI <0.001至0.25)独立关联于银屑病关节炎与骨关节炎的鉴别。
  • 模型AUROC为0.99,仅用年龄和性别的模型AUROC为0.87(p<0.001)。
  • 验证样本中得到相似结果。

临床怎么用

  • 血清四标志物组合可能作为辅助工具鉴别银屑病关节炎与骨关节炎,但需进一步前瞻性验证。

局限性

  • 结果需在前瞻性研究中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to identify soluble biomarkers that differentiate psoriatic arthritis (PsA) from osteoarthritis (OA). METHODS: Markers of cartilage metabolism (cartilage oligomeric matrix protein [COMP], hyaluronan), metabolic syndrome (adiponectin, adipsin, resistin, hepatocyte growth factor [HGF], insulin, leptin) and inflammation (C-reactive protein [CRP], interleukin-1β [IL-1β], IL-6, IL-8, tumour necrosis factor alpha [TNFα], monocyte chemoattractant protein-1 [MCP-1], nerve growth factor [NGF]) were compared in serum samples from 201 patients with OA, 77 patients with PsA and 76 controls. Levels across the groups were compared using the Kruskal-Wallis test. Pairwise comparisons were made with Wilcoxon rank-sum test. Multivariate logistic regression analyses were performed to identify markers that differentiate PsA from OA. Receiver operating characteristic (ROC) curves were constructed based on multivariate models. The final model was further validated in an independent set of 73 PsA and 75 OA samples using predicted probabilities calculated with coefficients of age, sex and biomarkers. RESULTS: Levels of the following markers were significantly different across the three groups (p<0.001)-COMP, hyaluronan, resistin, HGF, insulin, leptin, CRP, IL-6, IL-8, TNFα, MCP-1, NGF. In multivariate analysis, COMP (OR 1.24, 95% CI 1.06 to 1.46), resistin (OR 1.26, 95% CI 1.07 to 1.48), MCP-1 (OR 1.10, 95% CI 0.07 to 1.48) and NGF (OR<0.001, 95% CI <0.001 to 0.25) were found to be independently associated with PsA versus OA. The area under the ROC curve (AUROC) for this model was 0.99 compared with model with only age and sex (AUROC 0.87, p<0.001). Similar results were obtained using the validation sample. CONCLUSION: A panel of four biomarkers may distinguish PsA from OA. These results need further validation in prospective studies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Chandran V, Abji F, Perruccio AV, et al. Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis. Ann Rheum Dis. 2019. PMID: 30910989. doi:10.1136/annrheumdis-2018-214737

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。